Clinical Trials Logo

Rare Tumor clinical trials

View clinical trials related to Rare Tumor.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03239015 Recruiting - Refractory Tumor Clinical Trials

Efficacy and Safety of Precision Therapy in Refractory Tumor

Start date: January 1, 2017
Phase: Phase 2
Study type: Interventional

This study is intended to evaluate efficacy and safety of targeted precision therapy in patients with refractory tumor, including rare tumor without standard recommended treatment and common tumor after multiple line of therapy.